Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03420456 · ClinicalTrials.gov registry record · NA
Transcranial Pulse Near-Infrared Light in Generalized Anxiety Disorder: a Placebo-Controlled Study
A NA study, sponsored by Massachusetts General Hospital.
- Terminated
- Registry status
- NA
- Development phase
- 17
- Enrollment target
NCT03420456: Clinical Trial NA study, sponsored by Massachusetts General Hospital.
NCT03420456 is a NA study that was terminated before completion, run by Massachusetts General Hospital. The registered enrollment target is 17 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03420456, a NA study, was terminated before completion, sponsored by Massachusetts General Hospital.
- TERMINATED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
Study Summary
Transcranial Light Therapy involves non-invasive and invisible beams of light that increase energy metabolism in the brain. Transcranial light therapy has been found to promote brain metabolism which may help people with anxiety. The research team proposes a novel approach to treating anxiety by using transcranial light therapy.
Interventions
- DEVICE Transcranial Light Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2018-09-24 |
| Est. Completion | 2019-05-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03420456
The ClinicalTrials.gov registry entry for NCT03420456 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Transcranial Light Therapy is the first listed.
NCT03420456 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03420456 about?
NCT03420456 is a clinical study titled "Transcranial Pulse Near-Infrared Light in Generalized Anxiety Disorder: a Placebo-Controlled Study". Transcranial Light Therapy involves non-invasive and invisible beams of light that increase energy metabolism in the brain. Transcranial light therapy has been found to promote brain metabolism which may help people with anxiety. The research team proposes a novel approach to treating anxiety by usi...
What is the current status of trial NCT03420456?
This trial is currently terminated. It is a NA study. The enrollment target is 17 participants. The study started on 2018-09-24. Estimated completion is 2019-05-06.
What interventions are being tested in trial NCT03420456?
The interventions under investigation include: Transcranial Light Therapy (DEVICE).
Who is sponsoring clinical trial NCT03420456?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.